NeoadjuvantTherapyFamilyHistoryHormoneReplacementTherapyMastectomyCytotoxicEGFRAdvocacyCMFChemotherapyCapecitabinePARPInhibitorsKappaEpsilonMetastasisRaloxifeneGeneticPredispositionIntraductalPapillomaBreastTomosynthesis1 in 8womenMultimodalityTherapyTriple +/-BreastCancerBilateralProphylacticMastectomyCachexiaLumpDimplingER+RadiotherapyBRCAGeneMastodyniaLapatinibAngiogenesisPhysicalactivity mayreduce therisk of breastcancersSERMPrecisionMedicineChemopreventionGuaranteedRenewableInsuranceBI-RADSCDK4/6InhibitorsBrachytherapyAdenocarcinomaMultifocalTumorsAlopeciaDown-StagingAntiemeticLymphoscintigraphyFlowCytometryAdjuvantTherapyAlcohol intakeof more thantwo drinks perday is a riskfactor for breastcancerMegestrolAcetateDoseDenseTherapyFISHKi-67RateRelapseCyclophosphamidePalbociclibDefinitiveSurgeryStagingAntibodyTherapyTyrosine-KinaseInhibitorGeneMutation5-FluorouracilAbsoluteRiskECOGScoreACChemotherapyHormoneReceptorStatusCytostaticGeneticCounselingCheckpointInhibitorSelf-examinationFibroadenomaWomen ages20-39 yoshould have aclinical breastexam at leastevery 3 years.PathologicResponsePhyllodesTumorAyurvedaLCISBiopsyLymphNodeStatusChemotherapyAfrican-Americanwomen have a lowerchance of breastcancer overall, butthey are 40% morelikely to die frombreast cancer thanwhite womenPagetDiseasePI3KinaseInhibitorsOligometastasesMRIGailModelAxillarySamplingER-HerceptinmTORInhibitorsCalcificationsApoptosisAnastrozoleTamoxifenPalpationRADOvarianSuppressionCo-survivorMammography is alow-dose X-rayexamination thatcan detect breastcancer two yearsbefore it is largeenough to be feltIn-situCarcinomaGenomicTestingCAMDoxorubicinHER-2BevacizumabCystBOCAFor every 1,000screeningmammogramsperformed, aboutfive breast cancersare detected.DocetaxelAromataseInhibitorsBreastCancerEstradiolTumorGradeImmunotherapyLumpectomyBreast cancer isthe leading causeof death in womenbetween the agesof 40 and 55MethotrexateEstrogenPaclitaxelGermlineMutationMorpheaWomen ages40+ shouldhave a clinicalbreast examat least yearlyEstimated 2,150 menwill be diagnosedwith breast cancerand approximately410 will die each yearProgestinNeoadjuvantTherapyFamilyHistoryHormoneReplacementTherapyMastectomyCytotoxicEGFRAdvocacyCMFChemotherapyCapecitabinePARPInhibitorsKappaEpsilonMetastasisRaloxifeneGeneticPredispositionIntraductalPapillomaBreastTomosynthesis1 in 8womenMultimodalityTherapyTriple +/-BreastCancerBilateralProphylacticMastectomyCachexiaLumpDimplingER+RadiotherapyBRCAGeneMastodyniaLapatinibAngiogenesisPhysicalactivity mayreduce therisk of breastcancersSERMPrecisionMedicineChemopreventionGuaranteedRenewableInsuranceBI-RADSCDK4/6InhibitorsBrachytherapyAdenocarcinomaMultifocalTumorsAlopeciaDown-StagingAntiemeticLymphoscintigraphyFlowCytometryAdjuvantTherapyAlcohol intakeof more thantwo drinks perday is a riskfactor for breastcancerMegestrolAcetateDoseDenseTherapyFISHKi-67RateRelapseCyclophosphamidePalbociclibDefinitiveSurgeryStagingAntibodyTherapyTyrosine-KinaseInhibitorGeneMutation5-FluorouracilAbsoluteRiskECOGScoreACChemotherapyHormoneReceptorStatusCytostaticGeneticCounselingCheckpointInhibitorSelf-examinationFibroadenomaWomen ages20-39 yoshould have aclinical breastexam at leastevery 3 years.PathologicResponsePhyllodesTumorAyurvedaLCISBiopsyLymphNodeStatusChemotherapyAfrican-Americanwomen have a lowerchance of breastcancer overall, butthey are 40% morelikely to die frombreast cancer thanwhite womenPagetDiseasePI3KinaseInhibitorsOligometastasesMRIGailModelAxillarySamplingER-HerceptinmTORInhibitorsCalcificationsApoptosisAnastrozoleTamoxifenPalpationRADOvarianSuppressionCo-survivorMammography is alow-dose X-rayexamination thatcan detect breastcancer two yearsbefore it is largeenough to be feltIn-situCarcinomaGenomicTestingCAMDoxorubicinHER-2BevacizumabCystBOCAFor every 1,000screeningmammogramsperformed, aboutfive breast cancersare detected.DocetaxelAromataseInhibitorsBreastCancerEstradiolTumorGradeImmunotherapyLumpectomyBreast cancer isthe leading causeof death in womenbetween the agesof 40 and 55MethotrexateEstrogenPaclitaxelGermlineMutationMorpheaWomen ages40+ shouldhave a clinicalbreast examat least yearlyEstimated 2,150 menwill be diagnosedwith breast cancerand approximately410 will die each yearProgestin

BOCA Bingo - Call List

(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
  1. Neoadjuvant Therapy
  2. Family History
  3. Hormone Replacement Therapy
  4. Mastectomy
  5. Cytotoxic
  6. EGFR
  7. Advocacy
  8. CMF Chemotherapy
  9. Capecitabine
  10. PARP Inhibitors
  11. Kappa Epsilon
  12. Metastasis
  13. Raloxifene
  14. Genetic Predisposition
  15. Intraductal Papilloma
  16. Breast Tomosynthesis
  17. 1 in 8 women
  18. Multimodality Therapy
  19. Triple +/- Breast Cancer
  20. Bilateral Prophylactic Mastectomy
  21. Cachexia
  22. Lump
  23. Dimpling
  24. ER+
  25. Radiotherapy
  26. BRCA Gene
  27. Mastodynia
  28. Lapatinib
  29. Angiogenesis
  30. Physical activity may reduce the risk of breast cancers
  31. SERM
  32. Precision Medicine
  33. Chemoprevention
  34. Guaranteed Renewable Insurance
  35. BI-RADS
  36. CDK4/6 Inhibitors
  37. Brachytherapy
  38. Adenocarcinoma
  39. Multifocal Tumors
  40. Alopecia
  41. Down-Staging
  42. Antiemetic
  43. Lymphoscintigraphy
  44. Flow Cytometry
  45. Adjuvant Therapy
  46. Alcohol intake of more than two drinks per day is a risk factor for breast cancer
  47. Megestrol Acetate
  48. Dose Dense Therapy
  49. FISH
  50. Ki-67 Rate
  51. Relapse
  52. Cyclophosphamide
  53. Palbociclib
  54. Definitive Surgery
  55. Staging
  56. Antibody Therapy
  57. Tyrosine-Kinase Inhibitor
  58. Gene Mutation
  59. 5-Fluorouracil
  60. Absolute Risk
  61. ECOG Score
  62. AC Chemotherapy
  63. Hormone Receptor Status
  64. Cytostatic
  65. Genetic Counseling
  66. Checkpoint Inhibitor
  67. Self-examination
  68. Fibroadenoma
  69. Women ages 20-39 yo should have a clinical breast exam at least every 3 years.
  70. Pathologic Response
  71. Phyllodes Tumor
  72. Ayurveda
  73. LCIS
  74. Biopsy
  75. Lymph Node Status
  76. Chemotherapy
  77. African-American women have a lower chance of breast cancer overall, but they are 40% more likely to die from breast cancer than white women
  78. Paget Disease
  79. PI3 Kinase Inhibitors
  80. Oligometastases
  81. MRI
  82. Gail Model
  83. Axillary Sampling
  84. ER-
  85. Herceptin
  86. mTOR Inhibitors
  87. Calcifications
  88. Apoptosis
  89. Anastrozole
  90. Tamoxifen
  91. Palpation
  92. RAD
  93. Ovarian Suppression
  94. Co-survivor
  95. Mammography is a low-dose X-ray examination that can detect breast cancer two years before it is large enough to be felt
  96. In-situ Carcinoma
  97. Genomic Testing
  98. CAM
  99. Doxorubicin
  100. HER-2
  101. Bevacizumab
  102. Cyst
  103. BOCA
  104. For every 1,000 screening mammograms performed, about five breast cancers are detected.
  105. Docetaxel
  106. Aromatase Inhibitors
  107. Breast Cancer
  108. Estradiol
  109. Tumor Grade
  110. Immunotherapy
  111. Lumpectomy
  112. Breast cancer is the leading cause of death in women between the ages of 40 and 55
  113. Methotrexate
  114. Estrogen
  115. Paclitaxel
  116. Germline Mutation
  117. Morphea
  118. Women ages 40+ should have a clinical breast exam at least yearly
  119. Estimated 2,150 men will be diagnosed with breast cancer and approximately 410 will die each year
  120. Progestin